Morgan Roupret, MD, PhD, from the Pitié-Salpétrière Hospital, Paris, France, discusses management of side effects in treatment of bladder cancer at the European Association of Urology (EAU) conference 2017 in London, UK. He states that in the near future, medication delivered directly to the bladder will be available to reduce the side effects of BCG and chemotherapy.
